Top Analyst Reports For Texas Instruments, Blackstone & Northrop Grumman

 | Jul 25, 2019 02:58AM ET

Thursday, July 25, 2019

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments (TXN), Blackstone (NYSE:BX) and Northrop Grumman (NOC). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see

Texas Instruments’ shares have gained +35.6% year to date, outperforming the Zacks General Semiconductor industry which has increased +23.2% over the same period. Texas Instrument delivered better than expected second quarter results. However, both earnings and revenues declined on a year-over-year basis.

The company witnessed sluggishness across both the Analog and Embedded Processing segments owing to overall weak demand environment. Nevertheless, Texas Instruments has revised its guidance for 2019 revenues upward despite slowdown in chip sales globally. The Zacks analyst thinks this is likely to help the company in winning shareholders’ confidence.

Moreover, the company remains confident on portfolio strength, efficient manufacturing strategies and optimized capital allocation in growth areas. Further, growing investments in industrial and automotive markets are positives. However, U.S.-China trade tensions is a major headwind.

(You can ).

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Shares of Blackstone have outperformed the Zacks Investment Management industry over the past six months, (+48.5% vs. +12.1%). The company’s earnings surpassed expectations in two of the trailing four quarters. Its second-quarter 2019 results benefited from lower expenses, partly offset by a decline in revenues. The Zacks analyst thinks the company remains well positioned to capitalize on its fund-raising ability.

Also, it will likely benefit from revenue mix, inorganic growth efforts and persistent asset inflows. The company has converted itself from a publicly traded partnership to a corporation, which will help it attract more investors for its stock.

However, mounting expenses (mainly due to higher general and administrative costs) will likely hurt bottom-line growth. Moreover, the company’s capital deployment activities look unsustainable which remain a major near-term concern.

(You can ).

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Northrop Grumman’s shares have outperformed the Zacks Aerospace Defense industry over the past year, gaining +20.1% over the period versus the industry’s +5% increase. Northrop Grumman ended second-quarter 2019 on an impressive note, wherein both earnings and revenues surpassed their respective expectations.

The Zacks analyst thinks that since it is a major U.S. defense contractor, Northrop Grumman continues to enjoy a strong position in the Air Force, Space & Cyber Security programs. Increasing international opportunities are expected to boost the company’s margin growth.

However, it continues to incur high operating expenses on account of increasing product costs. Such higher operating expenses tend to hurt profit margins. A comparative analysis of its historical EV/EBITDA ratio depicts a relatively gloomy picture that might be a cause for concern.

(You can ).

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Other noteworthy reports we are featuring today include Capital One Financial (COF), Biogen (BIIB) and Sherwin-Williams (SHW).

This Could Be the Fastest Way to Grow Wealth in 2019

Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.

These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly

Today's Must Read/h6

Featured Reports/h6

Kinder Morgan's proposed Permian Highway Pipeline (PHP) project will help it cash in on the prolific basin???s bottlenecks. However, a levered balance sheet is worrying, per the Zacks analyst.

The Zacks analyst likes Biogen's strong portfolio of multiple sclerosis (MS) drugs and efforts to foray into other areas. However, MS is a competitive space.

While Sherwin-Williams should gain from synergies of the Valspar acquisition, hefty costs related to the buyout will weigh on its FY19 earnings, per the Zacks analyst.

Per the Zacks analyst, focus on credit card and online banking operations, solid loan growth and strong balance sheet aid Capital One.

Per the Zacks analyst, strong transcatheter aortic valve replacement sales in the domestic and global markets is a major positive.

Per the Zacks analyst, increasing card sales volume, supported by alliances and partnerships has driven performance.

Per the Zacks analyst, Snap benefits from improving user growth driven by strong adoption of Augmented Reality (AR) Lenses and demand for premium content.

New Upgrades/h6

Per the Zacks analyst, V.F. Corp's Vans brand is displaying strength globally with robust growth in all regions, channels and product categories. Sales for Vans grew 23% in first-quarter fiscal 2020.

The Zacks analyst likes the uptick in passenger revenues at JetBlue on the back of strong demand for air travel. Efforts to upgrade its fleet are also encouraging.

The Zacks analyst believes that the proximity of Murphy USA's fuel stations to Walmart supercenters helps the company leverage the strong and consistent traffic that these stores attract.

New Downgrades/h6

Per the Zacks analyst, Chipotle is plagued by costs related to marketing and promo initiatives. Additionally, higher food and labor costs are hurting the company of late.

Per the Zacks analyst, rising R&D expenses due to realization of electrification objectives and propulsion solutions are hampering its margin. Huge dependence on a few customers is worrisome.

Per Zacks analyst, efforts to bolster HSA Bank segment and transform Community Banking unit keep Webster Financial's costs high. Also, substantial exposure to commercial loans keeps us apprehensive.


undefined Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes